Recently, Kampo medicines (Japanese traditional herbal medicines) have been contributing greatly to patient treatment but there have been cases in which the patient's symptoms deteriorated during treatment and they had to discontinue the Kampo medicines. We investigated the reasons for discontinuing Kampo medicines at our institute, and discussed the improvement of continuance through giving patients better instructions. The most frequent reason for discontinuance was aggravation of symptoms by the medicines and we determined this by making a classification of the reasons for discontinuation. The next most frequent reason for discontinuance was digestive tract-related and other symptoms, for example rash and/or itch, and diarrhea. Next, we examined these symptoms to see if they were related to the adverse effects of Kampo medicines.
Introduction
Based on Kampo theory, Kampo therapy emphasizes concern for specific patient complaints and physical symptoms rather than the name of diseases in treatment. Patients who wish for not only Western medicine but also Kampo Medicine are increasing. In modern medicine the expectation for Kampo Medicine is getting higher and higher1-3). And it is becoming more common for pharmacists to dispense Kampo medicines4).
Kampo medicines are used for many diseases and have contributed greatly to patient treatment. However, there also exist cases in which the patients' symptoms deteriorate during Kampo medicines treatment and the treatment has to be discontinued. To investigate the reasons for discontinuance of Kampo medicines and to discuss the relationship between Kampo medicines and the reasons for their discontinuance are critical steps in aiding pharmacists to give proper patient instructions regarding Kampo medicines. After receiving permission from our institute's ethics committee, we investigated the cases in which Kampo medicines were discontinued at our institute. Based on the results of this investigation, we examined how to improve continuance of Kampo medicines through improving pharmacist' patient instructions.
Methods

Period and Subject of Investigation
We investigated the cases in which prescribed Kampo medicines were discontinued by doctors at the outpatient Kampo clinic of Oriental Medicine Research Center of the Kitasato Institute, during the period from May 2000 to December 2003 (44 months).
Classification of Reasons for Discontinuance
We classified the reasons for discontinuance of Kampo medicines into three categories : symptoms found after tak- In this investigation, no relation was found between treatment periods and discontinuance.
The Reasons for Discontinuance of Kampo Medicines
Among the 351 cases of discontinuance of Kampo medicines, the most frequent reason for discontinuance was because of the occurrence of symptoms after taking the medicines (265 cases). The second reason given was taste and/or smell (37 cases). There were 49 cases categorized as "others" (Fig. 1) .
In cases of discontinuance because of the taste and/or smell of Kampo medicines, most complaints were "could not drink because it smelled of cinnamon," "could not drink because it was too bitter," "could not drink because it smelled like medicine," and etc. Related to the smell of cinnamon, there were 10 cases in which the prescriptions included Cinnamoni Cortex. There were 6 cases in which the prescriptions included Coptidis Rhizoma, which is very bitter. However, there were 21 cases not related to Cinnamoni Cortex and Coptidis Rhizoma in which the reason for discontinuance was the complex taste of the Kampo medicines, and not the taste of a specific ingredient.
Other reasons for discontinuance included cases in which the patients overreacted on information regarding adverse effects ; cases in which the patients preferred their previous prescriptions to the new ones ; and cases in which Kampo medicines were discontinued because of pregnancy or death.
In cases of discontinuance due to the occurrence of symptoms after taking the medicines, there were 109 cases in which the main complaint was aggravated. There were 72 cases of upper digestive track symptoms, 54 cases of lower digestive track symptoms, 44 cases of skin symptoms, 44 cases of psychological nervous system symptoms, 27 cases of respiratory organs symptoms, and 79 cases of others.
We classified the main disease and other diseases into categories according to the symptoms (Fig. 2) .
A. Among the 109 cases of main complaint aggravation, 66 cases were because of skin symptoms such as rash and/ or itch, 17 cases were because of lower digestive track symptoms such as diarrhea and/or abdominal pain, and 6 cases were because of sleeplessness.
Classification of cases of diseases other than main complaint aggravation is as follows : B. Among 72 cases of upper digestive track symptoms, there were 28 cases of nausea and/or vomiting, 14 cases of stomachache, and 14 cases of epigastic distress.
C. Among 54 cases of lower digestive track symptoms, there were 33 cases of diarrhea, 9 cases of abdominal pain, and 6 cases of constipation.
D. Among 44 cases of skin symptoms, there were 28 cases of rash, and 9 cases of itch.
E. Among 44 cases of psychological nervous system symptoms, there were 8 cases of headache and/or sluggishness, 7 cases of sleeplessness, and 6 cases of dizziness.
F. Among 27 cases of respiratory organs symptoms, there were 10 cases of cough and/or phlegm, 7 cases of dyspnea, 6 cases of fever.
G. There were 79 cases that do not fit in any of the above categories, including 15 cases of edema, 14 cases of liver dysfunction, 14 cases of fever, 11 cases of labial paralysis, 6 cases of stiff neck, 6 cases of paralysis of hand and/or feet, and 6 cases of body ache.
We found that skin symptoms in main complaint aggravation, diarrhea in lower digestive track symptoms, and rash in skin symptoms accounted for over 60% of incidents. On the other hand, in the group of psychological nervous system 
The Prescriptions Related to the Discontinuance and the Source Herbal Medicines
We investigated prescriptions and herbal medicines that were reported to have adverse effects".
Furthermore, in this investigation we determined the adverse effects of herbal medicines and their rate of occurrence (Table 1 ). Based on this adverse effect report, we examined the prescriptions related to the discontinuance and the source herbal medicines. For each symptoms (except E : psychological nervous system symptoms), we investigated the ingredient herb medicines that were included in two or more prescriptions used in discontinuance cases, examined the herbal medicines related to adverse effects and prescriptions that have these herbal medicines, and the relations to other adverse effects (Table 2) F. Respiratory organs For dyspnea, there were 2 cases of Orengedokuto (JTDN), which was reported to have the adverse effect of dyspnea from interstitial pneumonia.
G. Others Among the prescriptions in which edema appeared, 10 had Glycyrrhizae Radix. It was reported that Glycyrrhizae Radix has the adverse effect of edema. Among the 14 prescriptions in which liver dysfunction occurred, 8 were reported to have the adverse effect of liver dysfunction aggravation, and 7 contained Saiko-zai (the name of prescription that has Bupleuri Radix (5-7 g)). It was reported that the prescriptions in which fever occurred had the adverse effect of interstitial pneumonia. Also, in 3 of the prescriptions in which fever occurred, liver dysfunction occurred too. For labial paralysis, there were 3 prescriptions that had Aconiti Tuber. It was reported that Aconiti Tuber had the adverse effect of labial paralysis.
Prevention Measures Based on the Investigation Results
1) When a doctor decided to discontinue Kampo medicines due to the occurrence of symptoms after medicines were taken, the reasons for discontinuance were recorded in the clinical record. However, in some cases, if one only depends on the clinical record, it is hard to understand the relation between the reasons for discontinuance and the Kampo medicines. Therefore, in addition to the clinical record, we required that the reasons for discontinuance be recorded on a "Discontinuance Sheet" maintained by the pharmacists (Fig. 3) . The original "discontinuance sheet" recorded by the doctor is attached to the clinical record, and a copy of it is distributed to the pharmacy so the necessary information is recorded in the patients' pharmaceutical history. This made it possible for pharmacists to understand the reasons for discontinuance in detail.
2) When the reasons for discontinuance are related to Kampo medicines and herbal medicines, the related medicines should be recorded at the "forbidden/allergy" column in both the clinical record and the pharmaceutical history. Furthermore, red marks are made on the right corner of both sides of the pharmaceutical history to distinguish it from other pharmaceutical histories. In this way, we have prevented the Kampo medicines or herbal medicines that were the reason for discontinuance from being prescribed again.
3) We required distribution of the medical history questionnaire filled in by new patients before their examination. Referring to the questionnaire, pharmacists are able to understand the current medical history of new patients when they dispense Kampo medicines or give patient instructions, pharmacists can also check if there is a potential problem when using Kampo medicines in conjunction with Western medicines or supplements. We also required checking for patients who are allergic to foods such as cinnamon, if herbal medicines containing such ingredients were included in the prescribed Kampo medicines. 4) When pharmacists give patients instructions, we require them to understand the tastes of prescribed Kampo medicines, and to make sure to explain the tastes to new patients or patients who had a new prescription.
Discussion
In this investigation, the rate of discontinuance of Kampo medicines because of adverse effects or other reasons was 0.29%. This is very low compared to other institutes"°). According to "A Classification Standard by Degrees of Seriousness for Side Effects Caused by Medical Supplies," the symptoms that occurred were very light, equal to grade 1"). Serious side effects found in general hospitals' report (grade 3) were not found12).
As for the reasons for discontinuance, cases in which symptoms occurred after taking Kampo medicines accounted 75 % of the total. The rate of skin symptom aggravation as the main complaint was especially high. This is probably because most of the outpatients of our institute had skin diseases"). Also, skin can be more sensitive to medicines. This is probably why there were more cases of discontinuance because of skin symptoms.
The next most common reason for discontinuance was digestive track symptoms : diarrhea was first, nausea and vomiting second. This is probably because many Kampo medi- 
